Successful treatment of a patient with SAPHO syndrome with certolizumab pegol

Rheumatology International

Volumn 35, Issue 9, 2015, Pages 1607-1608

  Kamata, Yasuyuki ^a   Minota, Seiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

ACNE; ADULT; ARTHRALGIA; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CASE REPORT; CYST; DISEASE ACTIVITY; DISEASE COURSE; DRUG CHOICE; DRUG EFFICACY; FEMALE; FOOT SOLE; HAND PALM; HUMAN; HYPEROSTOSIS; LETTER; MIDDLE AGED; MONOTHERAPY; OSTEITIS; PRIORITY JOURNAL; PUSTULOSIS; SAPHO SYNDROME; SYNOVITIS; TREATMENT RESPONSE; VISUAL ANALOG SCALE; ACQUIRED HYPEROSTOSIS SYNDROME; TREATMENT OUTCOME;

ACQUIRED HYPEROSTOSIS SYNDROME; CERTOLIZUMAB PEGOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84939471753     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-015-3263-8     Document Type: Letter

References (4)

1. Chamot AM, Benhamou CL, Kahn MF et al (1987) Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic 54:187–196
2. Benhamou CL, Chamot AM, Kahn MF (1988) Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 6:109–112
3. Sieper J, Rudwaleit M, Baraliakos X et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–ii44
4. Nguyen MT, Borchers A, Selmi C et al (2012) The SAPHO syndrome. Semin Arthritis Rheum 42:254–265